FRA
MOR

Front Row Advisors’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Front Row Advisors’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-265
Closed -$6 – 1100
2018
Q3 		$6 Sell
265
-1
-0.4% -$30 ﹤0.01% 539
2018
Q2 		$9 Buy
+266
New +$7.3K 0.01% 477

Other funds holding MOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Front Row Advisors's MOR Position: Q4 2018 in Review

Front Row Advisors sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2018, closing a stake of 265 shares — an estimated $6 sold.

Front Row Advisors first reported a position in MOR in Q2 2018 and held it in 2 quarters. The position peaked at $9 in Q2 2018. 30 funds tracked by Wall St. Rank hold MOR as of Q4 2018.

  • Front Row Advisors reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Front Row Advisors sold 265 MorphoSys AG American Depositary Shares shares in Q4 2018, an estimated $6.
  • Front Row Advisors first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 2 quarters.
  • Front Row Advisors's MorphoSys AG American Depositary Shares position peaked at $9 in Q2 2018.
  • 30 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2018.

Based on Front Row Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.